SCHEMBL29820198

SCHEMBL29820198

CC(n1ncc2cnc(Cl)nc21)C(C)(C)C#N

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.30
CLK4 Q9HAZ1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27156523 1.00 CSNK1A1 (0.30) CSNK1A1CLK4
SCHEMBL18366264 0.77 CDK1 (0.40)
SCHEMBL24267915 0.70 ADORA3 (0.32)
SCHEMBL29390081 0.70 ADORA3 (0.32)
SCHEMBL27156683 0.67 CA12 (0.30)
SCHEMBL27156681 0.67 CA12 (0.30)
SCHEMBL29819875 0.67 CA12 (0.30)
SCHEMBL29636852 0.65 PDE2A (0.47)
SCHEMBL13087506 0.65 PDE2A (0.47)
SCHEMBL30587629 0.64 AURKA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022197641-A1 1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL-AMINE DERIVATIVES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) MODULATORS AND/OR INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER DISEASES RAPT THERAPEUTICS, INC. (US) 2022-09-22 WO disclosed